These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 239736)

  • 41. [Serum carbohydrate 19-9 Tm and bronchial cancer. Comparative study with another tumor marker, carcinoembryonic antigen].
    Bisset JP; Kleisbauer JP; Roux F; Treffot MJ
    Pathol Biol (Paris); 1985 Jun; 33(6):672-6. PubMed ID: 3900886
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expression of HLA class I and II antigens in bronchogenic carcinomas: its relationship to cellular DNA content and clinical-pathological parameters.
    Redondo M; Concha A; Oldiviela R; Cueto A; Gonzalez A; Garrido F; Ruiz-Cabello F
    Cancer Res; 1991 Sep; 51(18):4948-54. PubMed ID: 1654207
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A normal adult and fetal lung antigen present at different quantitative levels in different histologic types of human lung cancer.
    Bell CE
    Cancer; 1976 Feb; 37(2):703-13. PubMed ID: 175912
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Distribution of a squamous cell lung carcinoma-associated antigen, KA-32, in human tissues and sera defined by monoclonal antibody KM-32.
    Hanai N; Shitara K; Yoshida H
    Cancer Res; 1986 Oct; 46(10):5206-10. PubMed ID: 3530436
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A thermostable antigen characteristic for carcinogen-induced rat intestinal tumors.
    Abeyounis CJ; Milgrom F
    J Immunol; 1976 Jan; 116(1):30-4. PubMed ID: 812915
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Antigens characteristic for tumors in bronchial carcinoma. 1 (author's transl)].
    Schlipköter HW; Idel H; Barsoum AL; Vollmer UJ
    Zentralbl Bakteriol Orig B; 1973 Oct; 158(2):109-24. PubMed ID: 4591798
    [No Abstract]   [Full Text] [Related]  

  • 47. A new and fast method of preparation of CEA.
    Burtin P; Chavanel G
    Ann Immunol (Paris); 1973 Nov; 124(4):583-7. PubMed ID: 4365352
    [No Abstract]   [Full Text] [Related]  

  • 48. HLA type and survival in lung cancer.
    Weiss GB; Nawrocki LB; Daniels JC
    Cancer; 1980 Jul; 46(1):38-40. PubMed ID: 7388766
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prolonged survival in bronchogenic carcinoma associated with HL-A antigens W-19 and HL-A5: a preliminary report.
    Dellon AL; Rogentine GN; chretien PB
    J Natl Cancer Inst; 1975 Jun; 54(6):1283-6. PubMed ID: 1133845
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Tumor-associated antigens in bronchial cancer].
    Gropp C
    Fortschr Med; 1982 Jun; 100(23):1100-7. PubMed ID: 6286437
    [No Abstract]   [Full Text] [Related]  

  • 51. Identification of a tumor-related protein antigen in immune complexes derived from pleural effusions of patients with bronchial carcinoma.
    Lawniczak M; Jezewska E; Górny MK; Zeromski J
    Neoplasma; 1985; 32(1):9-20. PubMed ID: 3982564
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunocytology of cancer.
    Davidsohn I; Ni LY
    Acta Cytol; 1970 May; 14(5):276-82. PubMed ID: 4935158
    [No Abstract]   [Full Text] [Related]  

  • 53. Antigens associated with chemically induced intestinal carcinomas of rats.
    Martin F; Martin MS; Bordes M; Knobel S
    Int J Cancer; 1975 Jan; 15(1):144-51. PubMed ID: 47840
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Study of substances related to carcinoembryonic antigens, CEA-NCA and association with alpha1-antichymotrypsin.
    Orjasaeter H
    Acta Pathol Microbiol Scand C; 1976 Jun; 84(3):235-44. PubMed ID: 63223
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunologic studies of glycoproteins isolated from cell membranes of human lung carcinomas.
    Tillack TW; Rosai J; Vervynck DJ
    J Natl Cancer Inst; 1974 Apr; 52(4):1059-67. PubMed ID: 4133198
    [No Abstract]   [Full Text] [Related]  

  • 56. Biological markers in human lung carcinoma: an immunopathological study of six antigens.
    Harach HR; Skinner M; Gibbs AR
    Thorax; 1983 Dec; 38(12):937-41. PubMed ID: 6198740
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunological detection of human bladder carcinoma.
    Monaco AP; Gozzo JJ; Schlesinger RM; Codish SD
    Ann Surg; 1975 Sep; 182(3):325-33. PubMed ID: 809015
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Antibodies against tumor associated antigens of human bronchogenic carcinoma: demonstration by anti-complement immunofluorescence (author's transl)].
    Schlipköter HW; Stiller-Winkler R; Idel H; Knopp J
    Zentralbl Bakteriol Mikrobiol Hyg B; 1981; 174(1-2):105-14. PubMed ID: 7034407
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A novel monoclonal antibody-defined antigen which distinguishes human non-small cell from small cell lung carcinomas.
    Sobol RE; Peters RE; Astarita RW; Hofeditz C; Masui H; Burton D; Handley HH; Glassy MC; Fairshter R; Carlo DJ
    Cancer Res; 1986 Sep; 46(9):4746-50. PubMed ID: 3015395
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Immunological studies and immunotherapeutic possibilities in inoperable bronchogenic carcinoma (author's transl)].
    Titscher R; Micksche M
    Prax Klin Pneumol; 1979 Apr; 33 Suppl 1():371-2. PubMed ID: 461311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.